Searched for: subject:"Tumor%5C%2BCells%2C%5C%2BCultured"
(1 - 2 of 2)
document
Gervois, P. (author), Vu-Dac, N. (author), Kleemann, R. (author), Kockx, M. (author), Dubois, G. (author), Laine, B. (author), Kosykh, V. (author), Fruchart, J.C. (author), Kooistra, T. (author), Staels, B. (author), Gaubius Instituut TNO (author)
Fibrinogen is a coagulation factor and an acute phase reactant up-regulated by inflammatory cytokines, such as interleukin 6 (IL-6). Elevated plasma fibrinogen levels are associated with coronary heart diseases. Fibrates are clinically used hypolipidemic drugs that act via the nuclear receptor peroxisome proliferator-activated receptor α (PPARα)...
article 2001
document
Vu-Dac, N. (author), Gervois, P. (author), Torra, I.P. (author), Fruchart, J.C. (author), Kosykh, V. (author), Kooistra, T. (author), Princen, H.M.G. (author), Dallongeville, J. (author), Staels, B. (author), Gaubius Instituut TNO (author)
Hypertriglyceridemia is a metabolic complication of retinoid therapy. In this study, we analyzed whether retinoids increase the expression of apo C- III, an antagonist of plasma triglyceride catabolism. In men, isotretinoin treatment (80 mg/d; 5 d) resulted in elevated plasma apo C-III, but not apo E concentrations. In human hepatoma HepG2 cells...
article 1998